secwatch.observer — SEC 8-K summary
======================================

Issuer:     Wellgistics Health, Inc. (WGRX)
CIK:        0002030763
Form:       8-K
Filed at:   2026-08-04T20:30:17+00:00
Accession:  0001493152-26-036005
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DataMEDS AI enters LOI to acquire QLPM IP, expand Datavault license, and take control of Tollo Health
--------------------------------------------------------------------------------

- MEDS to acquire QLPM IP from EOS and Scilex, expand Datavault AI Health license, and acquire controlling interest in Tollo Health (HLH).
- Post-closing ownership: EOS 19.9%, Scilex 19.9%, Datavault 19.9%, HBA 24.9%, Fortitude 5%, existing public ~10.4%.
- Gerald Commissiong appointed Interim Co-CEO; Dan Hirsch hired as Interim VP of Finance.
- Transaction subject to due diligence, definitive agreements, fairness opinion, stockholder and Nasdaq approvals; no assurance of completion.
- Minimum $2M investment from Dawson James investors; ATM facility to be filed within 14 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030763/000149315226036005/0001493152-26-036005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030763/000149315226036005/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-036005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer